These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 9743343

  • 1. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells.
    Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ.
    J Immunol; 1998 Sep 15; 161(6):2833-40. PubMed ID: 9743343
    [Abstract] [Full Text] [Related]

  • 2. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N, Poulaki V, Mitsiades C, Tsokos M.
    Cancer Res; 2001 Mar 15; 61(6):2704-12. PubMed ID: 11289151
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells.
    Song JH, Song DK, Herlyn M, Petruk KC, Hao C.
    Clin Cancer Res; 2003 Sep 15; 9(11):4255-66. PubMed ID: 14519653
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
    Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P.
    Cancer Res; 2001 Oct 01; 61(19):7339-48. PubMed ID: 11585775
    [Abstract] [Full Text] [Related]

  • 5. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 6. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A.
    Gynecol Oncol; 2004 Jun 01; 93(3):594-604. PubMed ID: 15196850
    [Abstract] [Full Text] [Related]

  • 7. Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
    Nguyen T, Zhang XD, Hersey P.
    Clin Cancer Res; 2001 Mar 01; 7(3 Suppl):966s-973s. PubMed ID: 11300498
    [Abstract] [Full Text] [Related]

  • 8. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S, Meyer E, Debatin KM.
    Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of CaMKII-mediated c-FLIP expression sensitizes malignant melanoma cells to TRAIL-induced apoptosis.
    Xiao C, Yang BF, Song JH, Schulman H, Li L, Hao C.
    Exp Cell Res; 2005 Mar 10; 304(1):244-55. PubMed ID: 15707589
    [Abstract] [Full Text] [Related]

  • 10. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 Mar 10; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 11. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 12. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis.
    Hernandez A, Thomas R, Smith F, Sandberg J, Kim S, Chung DH, Evers BM.
    Surgery; 2001 Aug 07; 130(2):265-72. PubMed ID: 11490359
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T, Suzuki H, Nagai S, Yamamoto K, Imakiire A, Takada E, Itoh M, Mizuguchi J.
    J Orthop Res; 2003 Sep 07; 21(5):949-57. PubMed ID: 12919886
    [Abstract] [Full Text] [Related]

  • 14. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A, Lam A, Datta R, Srivastava RK.
    Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196
    [Abstract] [Full Text] [Related]

  • 15. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).
    Pawlowski JE, Nesterov A, Scheinman RI, Johnson TR, Kraft AS.
    Anticancer Res; 2000 Apr 19; 20(6B):4243-55. PubMed ID: 11205254
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.
    Chawla-Sarkar M, Bae SI, Reu FJ, Jacobs BS, Lindner DJ, Borden EC.
    Cell Death Differ; 2004 Aug 19; 11(8):915-23. PubMed ID: 15118763
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.
    MacFarlane M, Harper N, Snowden RT, Dyer MJ, Barnett GA, Pringle JH, Cohen GM.
    Oncogene; 2002 Oct 03; 21(44):6809-18. PubMed ID: 12360407
    [Abstract] [Full Text] [Related]

  • 18. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis.
    Kontny HU, Hämmerle K, Klein R, Shayan P, Mackall CL, Niemeyer CM.
    Cell Death Differ; 2001 May 15; 8(5):506-14. PubMed ID: 11423911
    [Abstract] [Full Text] [Related]

  • 20. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.
    Ozoren N, Kim K, Burns TF, Dicker DT, Moscioni AD, El-Deiry WS.
    Cancer Res; 2000 Nov 15; 60(22):6259-65. PubMed ID: 11103780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.